Management of compound glycyrrhiza oral solution and recommendations

doi:10.19803/j.1672-8629.20230558

Abstract

Abstract: Objective To investigate the current management level of compound glycyrrhiza oral solution, and to offer recommendations for improvement. Methods Related literature was retrieved from CNKI, Wanfang, VIP, the website of the FDA of the United States, and the official websites of NMPA and provincial drug regulatory agencies of China before being summarized and analyzed. Results There were some problems with this solution, such as unstable preparation processes, incomplete standards for content determination, ambiguous instructions, and complicated ADRs during the use of compound glycyrrhiza oral solution in China. Conclusion It is recommended that ways to regulate similar drugs at home and abroad be referred to to optimize the regulations of CGOS, the targets of marketing and processes be standardized for enterprises, health care providers be better trained and related knowledge be made more accessible.

Key words: compound glycyrrhiza oral solution, opioids, drug addiction, drug abuse, drug safety, regulatory measures

CLC Number:

R974
R954

CAO Ying, ZHOU Huziwei, ZHU Lan, WANG Shengfeng. Management of compound glycyrrhiza oral solution and recommendations[J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 529-534.

Add to citation manager EndNote|Ris|BibTeX

URL: https://www.zgywjj.com/EN/10.19803/j.1672-8629.20230558

https://www.zgywjj.com/EN/Y2024/V21/I5/529

References

[1] NMPA. Notice on the Announcement of the Second Batch of National OTC Drug Catalogues[EB/OL].(2001-05-18)[2023-10-30]. https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20010518010101130.html.
[2] Chinese Pharmacopoeia Commission.Pharmacopoeia of the People's Republic of China, Volume I(中华人民共和国药典一部)[M]. Beijing: China Medical Science Press, 2020: 992-993.
[3] QIAO D, LI QY, SUN YF, et al.Segmental determination of seven components in compound glycyrrhiza oral solution by UPLC-MS/MS combined with lon switching technology[J]. Chinese Journal of Pharmaceuticals(中国医药工业杂志), 2014, 45(5): 470-473.
[4] XIE JX, DENG YP, SHI LW.The opioids crisis in the U.S. and the utilization and supervision of Analgesics in China[J]. Chinese Journal of Drug Abuse Prevention and Treatment(中国药物滥用防治杂志), 2020, 26(4): 192-197.
[5] ZHANG CW, SUN YL.A case of allergic shock caused by compound licorice oral liquid[J]. Chinese Journal of Pharmacoepidemiology(药物流行病学杂志), 2005, 14(6): 374-374.
[6] ZHANG L.Literature Analysis of 27 cases of adverse drug reactions induced by compound glycyrrhiza mixture/oral solution[J]. China Pharmacy(中国药房), 2015, 26(24): 3361-3363.
[7] YI CH, YAN J, SONG XN.A case of allergic reaction caused by compound licorice oral solution[J]. Chinese Medicine(中国医药), 2011, 6(10): 1172.
[8] WANG SH, CUI XL.Combined use of cefoxitin and compound licorice oral solution to induce disulfiram reaction[J]. Adverse Drug Reactions Journal(药物不良反应杂志), 2017, 19(2): 149-150.
[9] LIU WQ, LI MM, SU G, et al.A case of facial edema caused by compound licorice oral solution[J]. Chinese Medicine(中国医药), 2014, 9(11): 1720.
[10] SUN Y.A case of ethanol allergy caused by compound licorice oral solution[J]. The Medical Forum(基层医学论坛), 2020, 24(10): 1468-1469.
[11] XU L, CAI Y, ZHANG KH.Disulfilamide like reaction induced by the combination of laxocephalosporin and compound licorice oral solution[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2015, 35(6): 564.
[12] SHI FH.A case report of allergic reaction to infant oral compound licorice mixture[J]. Qinghai Medical Journal(青海医药杂志), 2017, 47(7): 22.
[13] LU H, SHI QZ, LIU FQ.One case of disulfiram like reaction induced by the combination of cefoperazone sodium and sulbactam sodium for injection with compound licorice oral solution[J]. Central South Pharmacy(中南药学), 2017, 15(12): 1802.
[14] WANG JP, LI CM, LIU ZF, et al.Analysis of 25 cases of allergic reactions caused by compound liquorice tablet/mixture/oral solution[J].Chinese Journal of Clinical Rational Drug Use(临床合理用药杂志), 2021, 14(11): 3-5.
[15] LI YB, ZHANG ZC, SONG ZL.Pareto diagram analysis of adverse reactions by compound glycyrrhiza oral solution[J]. Chinese Journal of Clinical Rational Drug Use(临床合理用药杂志), 2023, 16(32): 29-33.
[16] XU YJ, ZHANG J, GUO DH, et al.Analysis of 1230 cases of anaphylactic shock induced by drugs[J].Chinese Journal of Drug Application and Monitoring(中国药物应用与监测), 2020, 17(2): 99-103.
[17] Chinese Pharmacopoeia Commission.Pharmacopoeia of the People's Republic of China, Volume Ⅱ(中华人民共和国药典二部)[M]. Beijing: China Medical Science Press, 2020: 959.
[18] QIN QF, LIN H, LIAO Y.Investigation of Quality of 31 batches of compound glycyrrhiza oral solutions[J]. China Pharmacy(中国药房), 2008, 207(9): 689-691.
[19] LI HB, XIE YB, XIAO HB, et al.Improvement of preparing technique for compound glycyrrhiza oral solution[J]. Journal of International Pharmaceutical Research(国际药学研究杂志), 2017, 44(6): 660-662.
[20] Shaanxi Provincial Food and Drug Administration. Shaanxi Provincial Food and Drug Quality Announcement(No. 16 of2016)[EB/OL].(2016-04-16)[2023-10-30]. https://www.cqn.com.cn/ms/content/2016-04/26/content_2854164.htm.
[21] Fujian Provincial Food and Drug Administration. Fujian Province Drug Quality Announcement(Issue 3 of 2019, Total Issue 77)[EB/OL].(2019-11-28)[2023-10-30]. http://yjj.scjgj.fujian.gov.cn/yp/gstg/201911/t20191128_5140881.htm.
[22] NMPA. Announcement of the State Food and Drug Administration on 7 batches of drugs that do not comply with regulations (No. 78 of2021)[EB/OL].(2021-10-12)[2023-10-30]. https://www.nmpa.gov.cn/xxgk/ggtg/ypchj/ypgjjgg/20211012150748176.html.
[23] KE YJ, ZHANG Y, CAI B, et al.Process quality review analysis in hospital preparation compound glycyrrhiza oral solution[J]. Anhui Medical and Pharmaceutical Journal(安徽医药), 2022, 26(1): 205-208.
[24] NMPA. Announcement on Revising the Instructions for Cold Medicines Containing Codeine[EB/OL].(2018-09-06)[2023-10-30]. https://www.nmpa.gov.cn/xxgk/ggtg/ypshmshxdgg/ 20180906165801678.html.
[25] FDA. FDA Warns Consumers Not to Use Licorice Coughing Liquid[EB/OL].[2023-10-30]. https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-consumers-not-use-licorice-coughing-liquid.
[26] Guangxi Stitute for Food and Drug Control. Guangxi Food and Drug Inspection Institute officially opens personal entrusted inspection services in response to public expectations[EB/OL].(2021-07-15)[2023-10-30]. http://yjj.gxzf.gov.cn/xwdt/bjdt/t9533452.shtml.
[27] WebMD. Drugs & Medications.Acetaminophen W/Codeine 300Mg-30Mg Tablet-Uses, Side Effects, and More[EB/OL]. [2023-10-30]. https://www.webmd.com/drugs/2/drug-63338/acetaminophen-w-codeine-oral/details.
[28] FDA. Approved Drug Products with therapeutic equivalence evalutions 43re Edition[EB/OL].[2023-10-30]. https://www.fda.gov/media/72973/download.
[29] Natinal Library of Medicine. Dailymed.Acetaminophen and Codeine Phosphate solution[EB/OL].[2023-10-30]. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=83a536d8-385d-46ed-9cd2-47b7efe96ccf.
[30] HUO YF, XIE YJ, XU LL, et al.1160 cases of adverse reactions caused by compound liquorice tablets and risk factor[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2021, 18(12): 1176-1180.
[31] ZHUANG CY.Analysis of current situation of abuse monitoring of compound licorice tablets[J]. Strait Pharmaceutical Journal(海峡药学), 2022, 34(4): 169-171.
[32] NMPA. Announcement on Revising the Instructions for compound Glycyrrhiza Tablets[EB/OL].(2020-03-03)[2023-10-30]. https://www.nmpa.gov.cn/xxgk/ggtg/ypshmshxdgg/20200303171701693.html.